Latest Insider Transactions at Pmv Pharmaceuticals, Inc. (PMVP)
This section provides a real-time view of insider transactions for Pmv Pharmaceuticals, Inc. (PMVP). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PMV Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PMV Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Sep 29
2020
|
Ra Capital Management, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
950,000
+35.71%
|
$17,100,000
$18.0 P/Share
|
Sep 29
2020
|
Ra Capital Management, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
760,265
+50.0%
|
-
|
Sep 29
2020
|
Euclidean Capital LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
4,179,416
+50.0%
|
-
|
Sep 29
2020
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
6,114,330
+25.36%
|
-
|
Sep 29
2020
|
Boxer Capital, LLC |
BUY
Conversion of derivative security
|
Indirect |
60,837
+40.81%
|
-
|
Sep 29
2020
|
Boxer Capital, LLC |
BUY
Conversion of derivative security
|
Direct |
1,318,236
+26.01%
|
-
|
Sep 25
2020
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
950,000
+50.0%
|
$17,100,000
$18.0 P/Share
|
Sep 25
2020
|
Boxer Capital, LLC |
BUY
Open market or private purchase
|
Direct |
950,000
+50.0%
|
$17,100,000
$18.0 P/Share
|